Found 1 articles for: "Risankizumab"

Refractory Dissecting Cellulitis of the Scalp Treated With Risankizumab

March 2022 | Volume 21 | Issue 3 | Case Reports | 313 | Copyright © March 2022

Perifolliculitis capitis abscedens et suffodiens or dissecting cellulitis (DC) is a rare and chronic disease with a predilection for the occipital, vertex, and parietal scalp. DC is characterized by m...
Read More